Current Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease
- 59 Downloads
Nonalcoholic fatty liver disease (NAFLD) represents the most common liver disease, and it is expected to become the leading cause of end-stage liver disease in the near future. Bariatric operations have beneficial effects on NAFLD, inducing histological resolution of liver damage through weight loss-dependent and weight loss-independent mechanisms. Due to lack of randomized controlled trials, no specific guidelines have been established so far. Yet there is growing evidence that NAFLD will eventually become a formal indication for metabolic surgery. Data regarding the choice of procedure are conflicting, although gastric bypass seems to be slightly superior to sleeve gastrectomy. The purpose of this review is to provide an update on the ongoing research regarding the role of metabolic surgery in NAFLD management.
KeywordsNonalcoholic fatty liver disease Liver steatosis Steatohepatitis Bariatric surgery Metabolic surgery Gastric bypass Sleeve gastrectomy
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by authors.
For this type of study, formal consent is not required.
- 2.European Association for the Study of the L, European Association for the Study of D and European Association for the Study of O. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–402.Google Scholar
- 6.Younossi Z, Stepanova M, Ong JP, et al. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol. 2018;S1542–3565(18)30611–6. https://doi.org/10.1016/j.cgh.2018.05.057.
- 15.Schwenger KJP, Fischer SE, Jackson T, et al. In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control. Surg Obes Relat Dis. 2018;14(9):1233–1239. https://doi.org/10.1016/j.soard.2018.06.007.
- 20.Kalinowski P, Paluszkiewicz R, Ziarkiewicz-Wroblewska B, et al. Liver function in patients with nonalcoholic fatty liver disease randomized to Roux-en-Y gastric bypass versus sleeve gastrectomy: a secondary analysis of a randomized clinical trial. Ann Surg. 2017;266:738–45.CrossRefPubMedGoogle Scholar
- 55.Motamedi MAK, Khalaj A, Mahdavi M, et al. Longitudinal comparison of the effect of gastric bypass to sleeve gastrectomy on liver function in a bariatric cohort: Tehran obesity treatment study (TOTS). Obes Surg. 2018. https://doi.org/10.1007/s11695-018-3537-9.
- 61.Tan CH, Al-Kalifah N, Lee WJ, et al. HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis. Asian J Surg. 2018;42(1):203–208.Google Scholar
- 62.von Schonfels W, Beckmann JH, Ahrens M, et al. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score). Surg Obes Relat Dis. 2018;14(10):1607–1616.Google Scholar
- 69.Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, et al. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev. 2010;(1):CD007340.Google Scholar